2026 ICD-10-CM Diagnosis Code D47.9Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified

ICD-10-CM CodesC00–D49D37-D48D47

ICD-10-CM D47.9
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D47.9 is a billable ICD-10-CM diagnosis code for neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasms of unspecified nature or uncertain behavior.

Code Identity

ICD-10-CM Code
D47.9
Billable Status
Yes — Valid for Submission
Code Describes
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
Short Description
Neoplm of uncrt behav of lymphoid,hematpoetc & rel tiss,unsp
Parent Code
Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

Code Classification

ChapterC00–D49Neoplasms
SectionD37-D48Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
CategoryD47Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
This CodeD47.9Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acquired angioedema due to lymphoproliferative disorder
  • Acquired C1 esterase inhibitor deficiency
  • Angioedema due to disorder of kinin metabolism
  • Atypical lymphoproliferative disorder
  • Autosomal recessive lymphoproliferative disease
  • Chronic lymphoproliferative disorder of natural killer cells
  • Disease caused by Human herpesvirus 8
  • Drug-induced immunodeficiency
  • Germinotropic lymphoproliferative disorder caused by Human herpesvirus 8
  • Hematologic neoplasm of uncertain behavior
  • Iatrogenic immunodeficiency-associated lymphoproliferative disorder
  • Lymphoproliferative disorder
  • Lymphoproliferative disorder caused by methotrexate
  • Lymphoreticular tumor
  • Myeloid neoplasm associated with beta-type platelet-derived growth factor receptor gene rearrangement
  • Neoplasm of hematopoietic cell type
  • Plasma cell neoplasm
  • Progressively transformed germinal centers
  • Secondary autoimmune hemolytic anemia
  • Secondary autoimmune hemolytic anemia co-occurrent and due to lymphoproliferative disorder
  • Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood
  • Vasculitis due to lymphoproliferative disorder
  • Virus-associated atypical lymphoproliferative disorder

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Lymphoproliferative disease NOS

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Disease, diseased
      • lymphoproliferative

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO072
Neoplasms of unspecified nature or uncertain behavior
Default principal diagnosis: inpatient Yes · outpatient Yes

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
bone (periosteum) marrow NEC (any bone)C96.9C79.52D47.9D49.89
marrow (bone) NECC96.9C79.52D47.9D49.89
spine, spinal (column) marrow NECC96.9C79.52D47.9D49.89
vertebra (column) marrow NECC96.9C79.52D47.9D49.89

Patient EducationClinical

Blood Disorders

Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D47.9 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
238.79 Lymph/hematpoitc tis NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D47.9Overview

Is D47.9 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D47.9 group to?

When neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D47.9?

Under the General Equivalence Mappings, neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified converts to ICD-9-CM 238.79 (lymph/hematpoitc tis NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.